Primary |
Vitamin B12 Decreased |
100.0% |
|
|
Secondary |
Product Used For Unknown Indication |
16.2% |
Drug Use For Unknown Indication |
14.3% |
Sciatica |
11.7% |
Crohn's Disease |
9.1% |
Hypertension |
7.1% |
Convulsion |
3.9% |
Diabetes Mellitus |
3.9% |
Pain |
3.9% |
Rheumatoid Arthritis |
3.2% |
Cardiac Disorder |
2.6% |
Chronic Hepatitis C |
2.6% |
Hyperlipidaemia |
2.6% |
Hypoaesthesia |
2.6% |
Neuralgia |
2.6% |
Neuropathy Peripheral |
2.6% |
Pustular Psoriasis |
2.6% |
Vitamin B12 Deficiency |
2.6% |
Anaemia Macrocytic |
1.9% |
Depression |
1.9% |
Epilepsy |
1.9% |
|
Respiratory Failure |
10.3% |
Somnolence |
10.3% |
Cardiac Arrest |
6.9% |
Deep Vein Thrombosis |
6.9% |
Pain |
6.9% |
Vertigo |
6.9% |
Vitamin B12 Deficiency |
6.9% |
Death |
3.4% |
Disorientation |
3.4% |
Dizziness |
3.4% |
Dizziness Postural |
3.4% |
Gastrooesophageal Reflux Disease |
3.4% |
General Physical Health Deterioration |
3.4% |
Hepatic Function Abnormal |
3.4% |
Human Herpesvirus 6 Infection |
3.4% |
Hyperkalaemia |
3.4% |
Hypoaesthesia |
3.4% |
Hypoglycaemia |
3.4% |
Interstitial Lung Disease |
3.4% |
Lip Injury |
3.4% |
|
Concomitant |
Product Used For Unknown Indication |
48.3% |
Crohn's Disease |
6.4% |
Hypertension |
4.7% |
Rheumatoid Arthritis |
4.4% |
Pain |
4.0% |
Multiple Sclerosis |
3.9% |
Prophylaxis |
3.3% |
Vitamin Supplementation |
2.7% |
Non-small Cell Lung Cancer |
2.6% |
Drug Use For Unknown Indication |
2.6% |
Multiple Myeloma |
2.3% |
Depression |
2.0% |
Gastrooesophageal Reflux Disease |
2.0% |
Diabetes Mellitus |
1.9% |
Supplementation Therapy |
1.9% |
Osteoporosis |
1.8% |
Anxiety |
1.4% |
Hepatitis C |
1.4% |
Premedication |
1.3% |
Atrial Fibrillation |
1.3% |
|
Vomiting |
12.5% |
Weight Decreased |
12.4% |
Weight Increased |
6.7% |
White Blood Cell Count Decreased |
5.8% |
Pain |
5.4% |
Urinary Tract Infection |
5.4% |
Pyrexia |
5.3% |
Injection Site Pain |
4.8% |
Thrombocytopenia |
4.7% |
Pneumonia |
4.3% |
Nausea |
3.8% |
Vision Blurred |
3.8% |
Rash |
3.7% |
Urticaria |
3.6% |
Death |
3.4% |
Tremor |
3.1% |
Somnolence |
3.0% |
Pain In Extremity |
2.8% |
Off Label Use |
2.7% |
Pulmonary Embolism |
2.7% |
|